Vertex Pharmaceuticals Incorporated (Public,NASDAQ:VRTX) decreased -0.37%, to close at $35.34 and its overall traded volume was 630,062.00 shares during the last session against its average volume of 1.78M. VRTX opened the day at $35.39, it made an intraday low of $35.22 and an intraday high of $35.49. The stock has a 52 week low of $31.25 and 52 week high of $44.24. VRTX's market capitalization is 7.18B and it has 203.19M outstanding shares.
About Vertex Pharmaceuticals Incorporated (Public,NASDAQ:VRTX)
Vertex Pharmaceuticals Incorporated (Vertex) is engaged in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, the Company’s lead drug candidate, is an oral hepatitis C protease inhibitor and a new class of antiviral treatments in clinical development that target hepatitis C virus (HCV), infection. Telaprevir is being evaluated in a registration program focused on treatment-naïve and treatment-failure patients with genotype 1 HCV infection. VX-770, the lead drug candidate in its cystic fibrosis (CF), program is being evaluated in a registration program that focuses on patients with CF who have the G551D mutation in the gene responsible for CF. Vertex is conducting a number of Phase IIa clinical trials of its earlier-stage drug candidates. On March 12, 2009, Vertex acquired ViroChem Pharma Inc. (ViroChem).
Exelixis, Inc. (Public,NASDAQ:EXEL) decreased -1.38%, to close at $8.59 and its overall traded volume was 628,089.00 shares during the last session against its average volume of 2.57M. EXEL opened the day at $8.67, it made an intraday low of $8.54 and an intraday high of $8.79. The stock has a 52 week low of $2.86 and 52 week high of $9.20. EXEL's market capitalization is 936.18M and it has 108.98M outstanding shares.
About Exelixis, Inc. (Public,NASDAQ:EXEL)
Exelixis, Inc. (Exelixis) is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on discovery and development of small molecule drugs for cancer. The Company has a pipeline of compounds in various stages of development for the treatment of cancer and various metabolic, cardiovascular and inflammatory disorders. All of its development compounds were generated through its internal drug discovery activities, although it is developing certain of these compounds in collaboration with partners and has out-licensed others. The Company is focusing its development activities on its clinical compounds, XL184, XL147 and XL765. XL184, the Company’s advanced drug candidate, inhibits MET, VEGFR2 and RET, proteins that are key drivers of tumor growth and/or vascularization. XL147 is a selective inhibitor of PI3K while XL765 is a dual inhibitor of PI3K and mTOR.
Powerwave Technologies, Inc. (Public,NASDAQ:PWAV) increased 1.59%, to close at $2.56 and its overall traded volume was 619,026.00 shares during the last session against its average volume of 2.08M. PWAV opened the day at $2.50, it made an intraday low of $2.50 and an intraday high of $2.59. The stock has a 52 week low of $1.05 and 52 week high of $2.77. PWAV's market capitalization is 340.81M and it has 133.13M outstanding shares.
About Powerwave Technologies, Inc. (Public,NASDAQ:PWAV)
Powerwave Technologies, Inc. (Powerwave) is a global supplier of end-to-end wireless solutions for wireless communications networks. The Company’s business consists of the design, manufacture, marketing and sale of products to improve coverage, capacity and data speed in wireless communications networks, including antennas, boosters, combiners, cabinets, shelters, filters, radio frequency power amplifiers, remote radio head transceivers, repeaters, tower-mounted amplifiers and advanced coverage solutions. The products are utilized in wireless networks globally, which support voice and data communications by use of cell phones and other wireless communication devices. Powerwave sell the products to both original equipment manufacturers, which incorporate the products into their base stations.
Joy Global Inc. (Public,NASDAQ:JOYG) decreased -0.03%, to close at $86.99 and its overall traded volume was 618,856.00 shares during the last session against its average volume of 1.73M. JOYG opened the day at $87.00, it made an intraday low of $86.70 and an intraday high of $88.21. The stock has a 52 week low of $42.45 and 52 week high of $88.21. JOYG's market capitalization is 9.01B and it has 103.62M outstanding shares.
About Joy Global Inc. (Public,NASDAQ:JOYG)
Joy Global Inc. is a manufacturer and servicer of mining equipment for the extraction of coal and other minerals, and ores. The Company’s equipment is used in mining regions throughout the world to mine coal, copper, iron ore, oil sands and other minerals. Its underground mining machinery segment (Joy Mining Machinery or Joy) is a manufacturer of underground mining equipment for the extraction of coal and other bedded minerals and offers service locations near mining regions worldwide. Its surface mining equipment segment (P&H Mining Equipment or P&H) is a producer of surface mining equipment for the extraction of ores and minerals and provides operational support for many types of equipment used in surface mining. During the fiscal year ended October 29, 2010 (fiscal 2010), the Company completed the integration of Continental Crushing and Conveying by combining this segment into its Underground Mining Machinery and Surface Mining Equipment segments.
ADTRAN, Inc. (Public,NASDAQ:ADTN) increased 0.47%, to close at $36.38 and its overall traded volume was 611,815.00 shares during the last session against its average volume of 806,475.00. ADTN opened the day at $36.25, it made an intraday low of $36.22 and an intraday high of $36.72. The stock has a 52 week low of $20.76 and 52 week high of $36.85. ADTN's market capitalization is 2.30B and it has 63.09M outstanding shares.
About ADTRAN, Inc. (Public,NASDAQ:ADTN)
ADTRAN, Inc. designs, manufactures, markets and services network access solutions for communications networks. The Company maintains two operating divisions based on its product and service offerings: the Carrier Networks Division and the Enterprise Networks Division. The Carrier Networks Division provides products used by service providers to deliver voice, data and video services from their equipment, whether it is located in a central office or remote terminal location, to a customer’s premises. The Enterprise Networks Division provides products used by enterprise customers to construct voice, data and video networks within the customer’s site or among distributed sites. Its combined product portfolio for both divisions consists of approximately 1,700 high-speed network access and communication devices. On September 15, 2009, the Company acquired Objectworld Communications Corporation.
